PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
October 29, 2018Frontiers in ImmunologyOpen Access

Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

NJNicolas JacquelotCDConnie P.M. DuongGBGabrielle T. Belz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jacquelot et al. (2018) studied this question.

synapsesocial.com/papers/6a20afe7fb15484991e51bcchttps://doi.org/10.3389/fimmu.2018.02480
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemokine Signaling and Functional Responses: The Role of Receptor Dimerization and TK Pathway Activation2001 · 394 citations
  2. 2CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells2006 · 698 citations
  3. 3Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity1999 · 1,487 citations
  4. 4Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma2017 · 28 citations
  5. 5Human Melanoma Metastases Express Functional CXCR42006 · 131 citations